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Abstract Bone tissue engineering may provide an alter-
native to autograft, however scaffold optimisation is
required to maximize bone ingrowth. In designing scaffolds,
pore architecture is important and there is evidence that cells
prefer a degree of non-uniformity. The aim of this study was
to compare scaffolds derived from a natural porous marine
sponge (Spongia agaricina) with unique architecture to
those derived from a synthetic polyurethane foam.
Hydroxyapatite scaffolds of 1 cm3 were prepared via cera-
mic infiltration of a marine sponge and a polyurethane (PU)
foam. Human foetal osteoblasts (hFOB) were seeded at
1 9 105 cells/scaffold for up to 14 days. Cytotoxicity, cell
number, morphology and differentiation were investigated.
PU-derived scaffolds had 84–91 % porosity and 99.99 %
pore interconnectivity. In comparison marine sponge-
derived scaffolds had 56–61 % porosity and 99.9 % pore
interconnectivity. hFOB studies showed that a greater
number of cells were found on marine sponge-derived
scaffolds at than on the PU scaffold but there was no sig-
nificant difference in cell differentiation. X-ray diffraction
and inductively coupled plasma mass spectrometry showed
that Si ions were released from the marine-derived scaffold.
In summary, three dimensional porous constructs have been
manufactured that support cell attachment, proliferation and
differentiation but significantly more cells were seen on
marine-derived scaffolds. This could be due both to the
chemistry and pore architecture of the scaffolds with an
additional biological stimulus from presence of Si ions.
Further in vivo tests in orthotopic models are required but
this marine-derived scaffold shows promise for applications
in bone tissue engineering.
1 Introduction
Current clinical strategies for bone repair have accepted
limitations, such as adequate donor site morbidity, adequate
supply and concerns about disease transmission [1–3].
Synthetic bone graft materials are commercially available
but often their use in the clinic is limited as surgeons are
concerned by poor or variable clinical outcomes. The cri-
teria required of a bone graft material are many and varied
as they may need to support bone growth in a mechanically
loaded environment. Current opinion would suggest that the
material should be non-inflammatory, osteoconductive,
bioactive, bioresorbable, porous and have a degree of
mechanical strength [4].
The inclusion of porosity in this list created a dichotomy
between mechanical strength and percentage porosity and
sparked huge debate over optimum pore features; pore size,
connectivity of the pores (i.e. whether they are open
channels connecting to others or closed cul-de-sacs), their
tortuosity (the ‘‘difficulty’’ of the route through the
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material) and the overall porosity. Decades after Hulbert
and Klawitter suggested the use of porous structures to
improve bone integration into synthetic materials [5, 6],
there remains little consensus on the optimum pore size,
either for resorption or bone ingrowth [7], with suggestions
ranging from mean pore sizes of 100 lm to as large as
500 lm diameter [8]. More recently, the addition of
microporosity (\10 lm) has been shown to enhance bone
repair [9, 10] perhaps by improving fluid flow and pro-
moting neovascularization [11].
In truth, there is probably no single optimum pore size
and a range of pore diameters and pore features may allow
the material to function on a number of different levels.
Biomimetic strategies have led to the investigation of
naturally occurring porous structures as templates for bone
growth and the marine environment, in particular, is rich in
mineralizing organisms with porous structures, some of
which are currently being used as bone graft materials and
others that are in early stages of development [12]. The
naturally occurring interconnectivity, pore size distribution
and tortuosity provide unique templates for material design
that cannot be produced using current manufacturing
techniques replicated synthetically [13].
The authors have previously demonstrated the ability to
produce 3-D porous hydroxyapatite scaffolds from marine
sponge templates which preserve the porous architecture of
the organism [14, 15]. These scaffolds have both microp-
orosity and macroporosity with 99.9 % interconnectivity,
good permeability and improved mechanical properties
when compared to scaffolds derived from a synthetic
polymer foam [16]. The aim of the current study was to
assess the ability of the marine-derived scaffolds to support
osteoblast-like cell proliferation and differentiation in vitro
when compared to synthetic polymer-derived scaffolds
with the hypothesis that the naturally occurring pore
architecture of the marine-derived scaffolds would better
support cell growth and infiltration.
2 Materials and methods
2.1 Cell preparation
Two cell types were used for this study, human foetal
osteoblast cell line (hFOBs; LGC Standards, USA) and
primary guinea pig bone marrow stromal cells (gpBMSCs).
gpBMSCs were isolated from whole bone marrow fol-
lowing sacrifice. Briefly, both tibia and femora were dis-
sected out and cleaned of soft tissue. The ends of each bone
were removed and marrow flushed out with sterile phos-
phate buffered saline (PBS). Following centrifugation, the
cell pellet was re-suspended in 8 mL of PBS, layered
onto 4 mL of Lymphoprep (Sigma Aldrich, UK) and
centrifuged at 800 g for 40 min. The buffy layer was
removed, washed and re-suspended in complete medium
[DMEM supplemented with 20 % FBS ? 2 mM L-glu-
tamine ? 100 U/mL Pen/strep ? 2.5 lg/mL fungizone
(all Gibco from Life Technologies, UK)] for counting.
Cells were plated at 1 9 105 cells/cm2, left undisturbed for
7 days and then fed biweekly thereafter. Cells were pas-
saged (1 flask: 4 flasks) when approximately 90 % con-
fluent using 0.25 % trypsin/EDTA (Gibco).
2.2 Scaffold preparation
Scaffolds approximately 10 mm in diameter and 10 mm in
length were prepared of each material (Fig. 1). Ceramic slip
[14] and scaffold production [15] have been reported in
previous publications. Briefly, predominantly spherically
shaped particles of HA grade S-BM (Batch P260/S/BM/192;
Plasma Biotal Ltd, UK) between 820 nm and 16.2 lm were
mixed with 2 wt% ammonium polyacrylate (Darvan 821A;
R.T Vanderbilt Company, USA), an anionic polyelectrolyte.
Through the addition of ever decreasing amounts of HA
powder to a mixture of distilled water and Darvan 821A over
a period of 4 days, an 80 wt% (55.9 vol%) solid loaded slip
with a viscosity of 126 mPas was achieved.
Scaffold production involved submerging the flexible
polyurethane (PU) packaging foam ([10 mm, 10 mm
height; 60 pores/in2; density, 30 kg/m3) (Craftworld Ltd,
UK) and the marine sponge (10 9 10 9 7-12 mm),
Spongia agaricina (Pure Sponge UK Ltd, UK), in the
optimized 80 wt% HA slurry followed by squeezing in a
Collin W100T Two Roll Mill (LRS Planung and Tech-
nologie GMBH, Germany). The specimens were dried for
4 h and sintered in a box furnace (EliteThermal Systems
Ltd, UK) at 1300 C. A ramp rate of 5 C min-1, a cooling
rate of 3 C min-1, and a dwell time of 5 h were deter-
mined as the optimal sintering regime.
Using the theoretical density of fully densified poly-
crystalline HA (3.156 g cm-3), the relative density was
calculated for five scaffolds and an average porosity value
was obtained. Table 1 confirms that the pore characteristics
of the replicated scaffolds are similar to those previously
found. Elemental analysis was assessed using scanning
electron microscopy (SEM) and energy-dispersive X-ray
spectroscopy (EDX) at 15 kV accelerating voltage under
medium probe current (JEOL 6500F, JEOL Ltd., Japan).
Scaffolds were washed 93 in PBS and soaked in medium
overnight. With five repeats per material, scaffolds were
transferred to a new 48 well plate for addition of cells.
2.3 Cell seeding protocol
There is no standard procedure for seeding cells onto a 3D
scaffold in culture yet the time for initial cell attachment
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could be crucial to eventual colonization of the material.
For both cell types, two different loading protocols were
tested. In the first (method A), 1 9 105 cells in 50 lL of
complete medium appropriate to cell type (i.e. DMEM:
Ham’s F12 supplemented with 10 % foetal bovine serum
and 0.6 mg/mL geneticin [all Gibco,] for hFOBs and
DMEM plus supplements for gpBMSCs) were added to
each scaffold and incubated for 1 h before an additional
1 mL of medium was added to fill the well. In the second
protocol (method B), 1 9 105 cells in 20 lL of complete
medium were added to each scaffold. Every 30 min, an
additional 20 lL of medium was applied to prevent the
materials drying and, after 4 h, the wells were filled with
medium.
Cells were fed by complete changes of medium twice a
week. During the first medium change at day 4, cell death
was established by quantifying the release of lactate
dehydrogenase (LDH) into the culture medium using
CytoTox 96 non-radioactive assay (Promega, UK)
according to the manufacturer’s instructions. After 7 days
in culture, medium was removed, cells were washed twice
with PBS and then 700 lL of lysis buffer (0.1 % Triton
X-100 [Sigma Aldrich, UK] in PBS) was added to each
well. The plate was subjected to three cycles of freezing at
-80 C and thawing at 37 C to lyse all cells. A picogreen
Fig. 1 Gross images of Spongia agaricina (a) and polyurethane
sponge (d) templates before processing and HA marine sponge-
derived (b) and PU sponge-derived scaffolds (e) following
replication. EDX elemental analysis of HA scaffolds (c marine
derived; f PU derived) showing the presence of Mg (both scaffolds)
and Si (marine-derived)
Table 1 Characteristics of scaffolds derived from marine sponges
compared to polyurethane sponge
Marine sponge (%) PU sponge (%)
Microporosity 33.90 ± 4.66 14.72 ± 9.49
Macroporosity 34.22 ± 7.06 60.73 ± 13.26
Total porosity 67.8 ± 4.145 73.35 ± 2.83
Microporosity was defined as\10 lm diameter [10]. Mean ± SD
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assay (Quant-ITTM Picogreen, Molecular Probes, Invit-
rogen, UK) was then performed on the cell lysate according
to manufacturer’s instructions to establish cell number by
measuring the amount of dsDNA.
2.4 Cell attachment
Using seeding method B described above, 1 9 105 hFOBs
were loaded onto each material with 4–5 repeats per
experimental condition. Cell attachment to tissue culture
plastic was used as a positive control. Cells were fed by
complete change of medium twice a week. After 4, 7 and
14 days in culture, samples were washed 92 with PBS,
transferred to a clean 48 well plate and covered with
700 lL of lysis buffer for preparation of lysates as above.
LDH and picogreen assays were performed as above.
Additional scaffolds were prepared for qualitative
analysis by SEM and confocal microscopy. Cells (hFOBs
or gpBMSCs) were seeded onto 10 9 10 mm materials
using method B described above. After 7 days in culture,
samples for SEM were fixed in 2 % glutaraldehyde in
0.1 M sodium cacodylate buffer, washed 92 in sodium
cacodylate buffer and dehydrated through graded alcohols.
After drying with HMDS overnight, scaffolds were sputter
coated with gold and viewed on a scanning electron
microscope (JEOL 6500F, JEOL Ltd., Tokyo, Japan).
Scaffolds to be viewed by confocal microscopy were also
incubated for 7 days after which time viable cells were
labeled with fluorescent microspheres (CelLuminateTM,
Biocompatibles International, UK). CelLuminateTM
reagent was added to each well at concentration of 10 %
v/v and incubated for 24 h. After washing x3 in PBS,
materials were viewed on a confocal laser scanning
microscope (Carl Zeiss Image M1, Carl Zeiss Ltd, UK) at
an excitation wavelength of 580 nm.
In order to determine the extent of cell penetration
through the material, a set of 10 9 10 mm samples were
cut in half in cross-section and then placed back together
again (in order that they could be split at the end of the
experiment for internal analysis of cell distribution) before
hFOBs were seeded onto the top of the scaffold as the
protocol above. After 4 days, cells were stained with a
Live/Dead Reduced Biohazard Viability Kit (Molecular
Probes) according to the manufacturer’s instructions. Fol-
lowing staining, cells were fixed with 4 % glutaraldehyde,
washed with PBS and viewed on a confocal laser scanning
microscope as described above.
2.5 Cell differentiation
hFOBs were loaded onto scaffolds as previously described
and cultured in complete medium for 24 h after which
medium was replaced with osteogenic medium (i.e. for
hFOBs complete medium plus 50 lM ascorbate-2-phos-
phate: for gpBMSCs complete medium plus 50 lM
ascorbate-2-phosphate, 0.1 lM dexamethasone 10 lM b-
glycerophosphate). In addition, hFOBS were cultured at
39 C, a temperature that restricts proliferation and
encourages differentiation of this cell line. After 7 days,
four repeats per material were processed for determination
of alkaline phosphatase activity and the rest were analysed
for gene expression.
Alkaline phosphatase activity was measured in cell
lysates produced using the same method as described
previously for picogreen assay. Fifty microlitres of each
lysate and standard was transferred into a 96 well assay
plate. Standards were prepared from p-nitrophenol (Sigma
Aldrich) diluted with in lysis buffer (0.1 % Triton X-100 in
PBS). 200 lL of substrate buffer (p-Nitrophenylphosphate
disodium, SigmaTM104, dissolved in 1.5 M 2-Amino-2-
methyl-propanol, SigmaTM221) was added to each well and
incubated for 30 min at room temperature in the dark.
Following the addition of 50 ll of stop solution (1 M
NaOH) the absorbance was read at 405 nm using a Tecan
GENios microplate reader.
Expression of COL1A1 and osteocalcin genes were
measured using real-time PCR and compared to the
expression of the housekeeping gene, GAPDH. Total RNA
was extracted and pooled from five repeats of each material
using GenElute (Sigma Aldrich). Briefly, cells were lysed
in a 2-mercaptoethanol buffer, diluted with ethanol and
passed through an RNA binding column. RNA was eluted
and quantified using a NanoDropTM 1000 spectropho-
tometer (Thermoscientific from Life Technologies) before
being transcribed to cDNA (Transcriptor first strand cDNA
synthesis kit, Roche, UK) using the procedure for
Anchored-oligo(dT)18 primers. cDNA was stored at
-20 C before use. 2 lL of cDNA was added to 10 lL of
mastermix (Fast Start Taqman probes master, Roche), 1 lL
of Real-time Ready primer kit for each gene of interest
(Roche, UK) and dH2O to a final reaction volume of 20 lL.
The PCR reaction was performed in a Rotor-Gene Q (Qi-
agen, UK) at an annealing temperature of 60 C. Expres-
sion levels of all genes were normalized to GAPDH mRNA
levels.
2.6 Conditioned medium experiments
In order to establish if there were differences in the
chemical dissolution products from the materials that may
account for differences in cell response, a conditioned
medium experiment was performed.
Each material was soaked in complete hFOB culture
medium at 1 g/mL for 14 days. Samples of the conditioned
media were sent for analysis by inductively coupled
plasma–mass spectrometry (ICP-MS) whereby elemental
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analysis was performed to determine Ca, P, Mg and Si
concentrations using a Perkin Elmer Optical Emission
Spectrometer, Optima 4300DV. Prior to analysis the
machine was calibrated to 10 ppm with a detection limit of
0.01 mg/L. The remaining conditioned medium was dilu-
ted with complete medium to give final concentrations of
conditioned media of 1, 0.5, 0.25, 0.1, and 0.01 with
complete medium as control.
To evaluate cell response to conditioned media, hFOBs
were seeded at 1 9 105 cells/cm2 in 96 well plates and
allowed to adhere for 1 h at 33 C and 5 % CO2 atmo-
sphere. After this time, the growth medium was removed
and 200 ll of each concentration of conditioned media was
applied with four repeats. Medium was replaced with the
same concentration of conditioned medium after 24 h and
twice a week thereafter. A cytotoxicity assay was per-
formed on media removed at day 1 using LDH assay as
above. After 14 days in culture, cell lysates were prepared
as above and cell number established using picogreen
assay.
2.7 Statistics
Differences between groups were analysed using one way
ANOVA with Bonferroni’s post hoc testing. Differences to
control medium were determined using ANOVA with
Dunnett’s post hoc testing. Significance was accepted if
P\ 0.05.
3 Results
3.1 Seeding protocol
There was no significant difference in either cell number or
cell death between the two different methods used for cell
seeding (Fig. 2). As the trend was for slightly higher cell
numbers on each scaffold with method B, this method was
chosen for the remainder of the experiments.
3.2 Cell attachment
After 7 days in culture both materials supported hFOB and
gpBMSC attachment (Fig. 3). SEM showed that the cells
were elongated with extensive processes attaching to the
material surface (Fig. 3a, b). It was also possible to observe
cells deep within the scaffold microstructure by SEM and
this was confirmed by the presence of cells on the internal
cut surface of both materials showing cells in the centre of
the scaffold (Fig. 3c, d).
3.3 hFOB proliferation and differentiation
Both scaffolds had reduced cytotoxicity levels compared to
cells grown on tissue culture plastic (Fig. 4a) with cytotox-
icity on PU-derived scaffolds also significantly lower than
marine-derived scaffolds. As small amounts of LDH can be
released from viable cells, some of these differences may be
accounted for by differences in cell number. Importantly,
cell death levels across all experimental conditions was
relatively low. hFOB proliferation on both scaffolds
increasedwith time (Fig. 4b). At d4 cell numbers were lower
than that on tissue culture (TC) plastic control, this was
reversed by 7 days for marine-derived materials and by d14
for PU-derived materials at which time there was no sig-
nificant difference between groups. Scaffold type did not
have any effect on the osteogenic differentiation of the cells
as measured by alkaline phosphatase activity (Fig. 4c) and
collagen 1A1 and osteocalcin gene expression (Fig. 4d).
3.4 Conditioned medium experiments
There was an increase in cell death when hFOBs were
cultured in 100 % conditioned medium (CM) from all four
Fig. 2 Cell number (a) and cell death (b) results for each scaffold when incubated with hFOBs and gpBMSCs using two cell seeding protocols.
For details of protocols see text. Mean ? SD. n = 5. MS marine-derived scaffold, PU polyurethane-derived scaffold
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testing conditions (P\ 0.001, Fig. 5a). As the CM con-
centration was diluted however, there was no difference in
LDH release compared to control medium. There were no
significant differences between the CM derived from the
PU-derived scaffold compared to the marine-derived
scaffold.
Results from the picogreen assay show that there was a
trend towards an increase in cell number with increasing
concentration of CM from marine-derived scaffolds at d1
but these were not significantly different from control
(P = 0.055, Fig. 5b). In contrast, cell number showed a
bell-shape curve in response to fractions of CM from PU-
derived scaffolds at d1 which was significantly different
(P = 0.004 by ANOVA). Both the 0.1 and the 0.25 frac-
tions were significantly higher than control media (0.035
and 0.006 respectively), suggesting there is an optimum
concentration of soluble factors in this medium. By day 14,
this trend had reversed and there was now a significant
reduction in cell number with the 0.1 fraction of CM from
PU-derived scaffolds compared to control (P = 0.015,
Fig. 5c). The earlier trend seen in response to CM from
marine-derived materials had continued and now reached
statistical significance (P\ 0.001 by ANOVA); post hoc
testing showed this was significant at the highest two
fractions compared to control (P = 0.018 and P = 0.001).
ICP-MS analysis showed a number of differences
between the CM from marine-derived and PU-derived
scaffolds with an almost four-fold increase in Ca concen-
tration, a ten-fold decrease in P and increased amounts of
Si in the marine-derived media extracts (Table 2). This
reflects the presence of Si found in marine-derived scaf-
folds by EDX (Fig. 1).
4 Discussion
The hypothesis was that the naturally occurring, unique
pore architecture of the marine-derived scaffolds would
provide an enhanced environment for cell growth when
compared to a synthetic polymer derived scaffold. The
results showed that, although cells demonstrated good
attachment to both scaffold types, with an elongated
Fig. 3 Cells migrating into the
pores shown by SEM (a, b) on
PU-derived scaffolds
(gpBMSCs) and hFOBs on the
inner surface of marine-derived
(c) and PU-derived (d) scaffolds
following fluorescent labeling
of live cells (green). Dead cells
would be labeled red but none
are visible (Color figure online)
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morphology and extensive processes, they proliferated
faster and colonized the marine-derived scaffold more
quickly than the PU-derived scaffold. They were found at
the centre of both scaffolds, remaining viable to at least
14 days suggesting either that the cells were able to
migrate into the scaffolds or that they percolated significant
depths during seeding. These results confirm the promising
early qualitative results which suggested that osteoblast-
like cells and endothelial cells attached better to the mar-
ine-derived material [16]. The ability of the cells to dif-
ferentiate as shown by alkaline phosphatase activity and
expression of collagen IAI and osteocalcin genes was not
enhanced but, encouragingly, neither was it inhibited by
the scaffolds and osteoblast differentiation was maintained
at levels similar to the control. These results are similar to
those reported by others who found that osteoblast prolif-
eration and migration/penetration into scaffolds was
enhanced by pore size but differentiation or mineralization
was unaffected [17, 18].
The importance of pore characteristics in bone graft
materials has been well described [8, 9, 11, 19, 20]. Key
features include a range of pore sizes on both the micro and
macro scale, a degree of interconnectivity of the pores,
allowing fluid diffusion and cell migration through the
material, and finally a degree of tortuosity (scaffolds in
which the route through the material is straightforward tend
to reduce cell capture) [21]. The marine-derived hydrox-
yapatite scaffold provides all of these features with 33.9 %
microporosity, 34.2 % macroporosity, 99.9 % intercon-
nectivity and permeability similar to that of human bone
[16] and others have demonstrated optimum oxygen dif-
fusivity in scaffolds derived from marine sponge templates
compared to polyurethane foam [22].
However, the enhanced cell proliferation reported
within this study may not just be related to the architecture
of marine-derived scaffolds. EDX analysis showed that
marine-derived scaffolds contained Si which was not pre-
sent within the PU-derived scaffold and both scaffold types
contained similar amounts of Mg. Secondary ions, which
were once classified as impurities, have now been recog-
nized as important for bone repair, particularly as the
mineral phase of bone is non-stoichiometric HA and con-
tains a number of minor ions such as carbonate (CO3
2-),
magnesium (Mg2?) and silicate (SiO4
4-). This has led to
interest in ion-substituted ceramic materials as bone graft
materials [23].
In order to differentiate the effects of scaffold archi-
tecture from the effects of scaffold chemistry, a
Fig. 4 Cytotoxicity (a), cell proliferation (b) and osteogenic differ-
entiation (c, d) of hFOBs cultured on each material. Osteogenic
differentiation of hFOBs shown by alkaline phosphatase activity
normalised to lg of DNA (c) and expression of osteogenic genes
(d) at day 7. Mean ? SD. MS marine-derived scaffold, PU
polyurethane- derived scaffold, TC tissue culture plastic. **Statisti-
cally significantly different from other groups at the same time point
(P\ 0.01)
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conditioned medium experiment was performed. CM
derived from both scaffold types reflected the EDX ele-
mental analysis with confirmed presence of Mg in both and
the addition of Si in CM from the marine-derived scaffolds.
Although the sponge species used for fabrication of the
scaffolds does not contain spicules, it is believed that
harvesting methods adopted when collecting from the
Mediterranean Sea led to contamination with silicate spi-
cules derived from other species which then become
incorporated into the HA scaffold during sintering. In
addition, CM from the marine-derived scaffolds contained
more than three times the amount of Ca and a fraction of
the phosphorus levels compared to PU-derived scaffolds.
Results from the CM experiments suggest that cell
proliferation was increased initially (at day 1) by optimal
concentrations of CM from PU-derived scaffolds, with the
highest and lowest concentrations reducing proliferation.
Although this effect was later lost by day 14, this early
acceleration is most likely to be due to the presence of Mg
ions. Magnesium has been reported to enhance osteoblast
adhesion, increase angiogenesis in porous structures [24],
increase bone formation [25] and increase bioresorption
[26, 27]. Crucially, in vitro, several papers have reported
that high and low concentrations of Mg are inhibitory to
cell proliferation and/or cytotoxic but optimal concentra-
tions can enhance osteoblast proliferation and mineraliza-
tion [28, 29]. The findings of the current study support this
but would suggest that this initial increase is transitory.
CM from marine-derived materials, in contrast, did not
show the same bell-shape curve in cell proliferation with
decreasing concentration at day 1, despite similar concen-
trations of Mg as measured by ICP. This could mean that
the effects of the PU-derived CM are not related to Mg
content or, more likely, that the presence of Si or increased
Ca levels in the marine-derived extracts is masking the Mg
effects. Indeed, at day 14 the highest cell numbers were
seen with the highest concentrations of CM from marine-
derived materials. Si-based glasses (Bioglass) and Si-
substituted calcium phosphates (CaP) have been widely
studied in bone repair [30, 31]. Bioglass has been shown
to have proangiogenic properties [32–35], to bond directly
to bone [36], to support osteoblast attachment and differ-
entiation [37–39] and to enhance bone repair [31]. Similar
claims have been made for Si-substituted CaP ceramics
[40–42] and for other silica-based biomaterials [23, 43, 44]
however the mechanism of action is unknown and there is
some controversy over whether it is a direct effect of the
substituted ion or an indirect effect caused by changes to
Fig. 5 hFOB cell death at day 1 (a) and cell number after 1 day
(b) and 14 days (c) in culture with decreasing concentrations of
conditioned medium. MS marine-derived scaffold, PU polyurethane-
derived scaffold. Bars indicate mean ? SD. n = 4. #Statistically
different from 0 % control group at P\ 0.01 and *P\ 0.05
Table 2 Elemental analysis of concentrated (100 %) conditioned
media extracts from both scaffolds by inductively-coupled plasma-
mass spectroscopy
Marine derived Synthetic derived
Ca (mg/L) 193 59.1
P (mg/L) 3.44 30.1
Si (mg/L) 2.08 0.37
Mg (mg/L) 74.9 96.7
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the physical characteristics of the material [23, 30]. There
is growing evidence for a direct effect of Si on the path-
ways of bone formation however [45, 46] as, for example,
Beck et al. reported that silica nanoparticles mediated bone
formation by suppression of NF-jB [43], and others
reported that biosilica enhanced the expression of osteo-
protegerin (OPG) and runt-related transcription factor 2
(Runx-2) [47].
CM from marine-derived extracts also had increased Ca
levels and decreased P levels. Quite why the phosphate
disappeared in the marine-derived CM is unclear but others
have reported similar phenomena when producing CM
from bioactive glasses [48]. The authors attributed this to
surface reactions during ionic dissolution and suggested
that it could contribute to delayed differentiation of
osteogenic cells as there was no source of phosphate for
mineralization. There have not been any reports of an
increase in proliferation associated with low phosphate
levels so the effects seen here are more likely to be due to
other differences such as the Si and Ca levels. An increase
in Ca ion concentration to five times standard culture
medium has been shown to be associated with an increase
in rat bone marrow stromal cell proliferation, migration
and osteogenic differentiation, and increasing to levels
above this were found to inhibit the response [49]. Levels
in the CM from marine-derived materials used in this study
were 2.5 times higher than standard culture medium and
that from PU-derived materials were slightly lower than
standard medium (59 mg/L compared to 76 mg/L) so the
difference in Ca concentration could also be contributing to
the increase in cell proliferation reported here. In addition,
there is evidence that a sudden change in Ca concentration,
either higher or lower, can induce an increase in intracel-
lular Ca levels in osteoblasts [50], therefore, not only the
absolute increase in marine-derived CM but also the sud-
den switch to this media, may have induced a response in
the cells.
Ion substitution is generally considered a positive
addition to a ceramic material to enhance bone repair and
marine organisms are a rich source of these ions which can
become incorporated into a biomaterial when converting
the base mineral into CaP. For example, the aragonite
skeleton of cuttlefish can be converted to carbonated
hydroxyapatite [51–53] and two species of sea urchins rich
in Mg2? ions were found to produce Mg-substituted b-
tricalcium phosphate during the conversion process [54].
We have shown that, even when the marine organism is
simply used as a preform, biogenic ions are still incorpo-
rated into the end product and that these could have a
beneficial effect on the ability of the resulting scaffold to
support bone formation.
5 Conclusion
Three dimensional porous constructs have been manufac-
tured that support osteoblast attachment, proliferation and
differentiation but significantly more cells were seen on
marine-derived scaffolds using the sponge, Spongia agar-
cina, as a template. This could be related both to the
physical and chemical characteristics of the material, with
optimum pore characteristics in addition to a biological
stimulus from the presence of Si ions. Further in vivo tests
in orthotopic models are required but this marine-derived
scaffold shows promise for applications in bone tissue
engineering.
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